D-Dimer-Driven Anticoagulation Reduces Mortality in Intubated COVID-19 Patients: A Cohort Study With a Propensity-Matched Analysis

Frontiers in Medicine

Adam J. Singer¹  Wei Hou²  Kenneth Kaushansky³  Anthony A. Asencio⁴  Sima Mofakham⁴  Anthony Oganov⁴  Nathaniel A. Cleri⁴  Leor N. Alkadaa⁴  Charles B. Mikell⁴  Daniel N. Rutigliano⁵  James Vosswinkel⁵  Jerry A. Rubano⁵  Panagiotis Volteas⁵  Mark Talamini⁵  Panagiotis Drakos⁵  Apostolos K. Tassiopoulos⁶  Mohsen Bannazadeh⁶  Nicos Labropoulos⁷ 

[1] Department of Emergency Medicine, Renaissance School of Medicine, Stony Brook, NY, United States;Department of Family, Population and Preventive Medicine, Renaissance School of Medicine, Stony Brook, NY, United States;Department of Medicine, Renaissance School of Medicine, Stony Brook, NY, United States;Department of Neurosurgery, Renaissance School of Medicine, Stony Brook, NY, United States;Department of Surgery, Renaissance School of Medicine, Stony Brook, NY, United States;Department of Surgery, Renaissance School of Medicine, Stony Brook, NY, United States;Division of Vascular Surgery, Department of Surgery, Renaissance School of Medicine, Stony Brook, NY, United States;Division of Vascular Surgery, Department of Surgery, Renaissance School of Medicine, Stony Brook, NY, United States;

关键词: D-dimer-driven anticoagulation;    anticoagulation;    d-dimer;    thrombotic complications;    hypercoagulability;    COVID-19;   

DOI  :  10.3389/fmed.2021.631335

来源: Frontiers

【 授权许可】

CC BY